Ecron Acunova offers end-to-end services to bring generic products to market quickly and effectively. We support Abbreviated New Drug Application (ANDA) according to 505 (j) or 505b (2) to the US FDA for marketing authorization in USA and across the globe. Our services include study design, study conduct, bioanalysis, data standardization and analysis, dossier preparation, and regulatory support. Ecron Acunova is a part of TAKE Solutions Limited.